BRCA2 and breast cancer: As for BRCA2, mutations mapped to the BRC domains showed increased OC risk while mutations occurring at the 5′ and 3′ regions, corresponding approximately to the PALB2-binding and DBD domains, respectively, were associated with increased BC risk.